🇺🇸 FDA
Pipeline program

Leuprorelin Acetate Depot 3M

Leuprorelin-4002

Approved small_molecule completed

Quick answer

Leuprorelin Acetate Depot 3M for Central Precocious Puberty is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Central Precocious Puberty
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials